The Power of Adjustability
By Julian Upton
April 2, 2026
Sitting Down With… Ron Kurtz, President and Chief Executive Officer, RxSight
6 min read
False
Advertisement
Interview
"We Need Better Answers in Glaucoma"
March 31, 2026
Leading 2026 Power Lister Gus Gazzard on collaboration, data quality, and trial design
3 min read
Decoding Idiopathic Intracranial Hypertension
By Alun Evans
March 30, 2026
Marc Bouffard discusses Mass General Brigham’s recently launched initiative aimed at better understanding idiopathic intracranial hypertension
7 min read
Could NPDR Be Treated Orally?
March 24, 2026
Phase 1b results for danegaptide indicate promising safety profile in patients with non-proliferative diabetic retinopathy and macular edema
2 min read
Ophthalmology’s Role in the Opioid Crisis
By Alun Evans
March 19, 2026
Retrospective cohort study investigates how ophthalmologists can provide potentially life-saving care to substance use disorder patients
3 min read
Beyond IOP: The Mood Effects of CAIs
March 12, 2026
Evidence from large US dataset suggests topical carbonic Anhydrase Inhibitors may increase depression risk in glaucoma patients
3 min read
The Retina: A Window on Neurodegeneration
March 9, 2026
New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration
5 min read
Debunking Myths in Eye-Brain Health
March 6, 2026
Separating hype from clinical reality in AI-powered eye–brain assessment
4 min read
Targeting Trabecular Meshwork Metabolism
March 5, 2026
Study suggests potential new vitamin B3 treatment for glaucoma protection
4 min read
Military Discipline, Medical Optimism
By Julian Upton
February 25, 2026
Sitting Down With… Scott Barnes, Chief Medical Office, STAAR Surgical
3 min read
Browse by Subspecialties
False
Advertisement